Bridgewater Associates LP Cuts Stock Holdings in agilon health, inc. (NYSE:AGL)

Bridgewater Associates LP lowered its position in agilon health, inc. (NYSE:AGL) by 79.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,539 shares of the company’s stock after selling 92,761 shares during the period. Bridgewater Associates LP’s holdings in agilon health were worth $47,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the company. JPMorgan Chase & Co. increased its stake in agilon health by 326.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after buying an additional 1,083,492 shares during the last quarter. Inspire Investing LLC lifted its holdings in agilon health by 106.6% during the fourth quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock worth $413,000 after acquiring an additional 112,241 shares during the period. KLP Kapitalforvaltning AS purchased a new position in agilon health in the fourth quarter worth $111,000. Vanguard Group Inc. grew its stake in agilon health by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company’s stock valued at $59,114,000 after purchasing an additional 272,787 shares during the period. Finally, Raymond James Financial Inc. purchased a new stake in shares of agilon health during the 4th quarter valued at $33,000.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the stock. Needham & Company LLC restated a “hold” rating on shares of agilon health in a report on Friday, March 21st. Citigroup raised shares of agilon health from a “sell” rating to a “neutral” rating and lifted their price target for the stock from $1.75 to $2.25 in a report on Friday, January 10th. TD Cowen raised their target price on agilon health from $3.50 to $6.00 and gave the stock a “hold” rating in a research report on Tuesday, April 15th. Cowen reiterated a “hold” rating on shares of agilon health in a research note on Tuesday, April 15th. Finally, Stifel Nicolaus lifted their price objective on agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a report on Wednesday, February 26th. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and three have issued a buy rating to the company. According to MarketBeat, agilon health has an average rating of “Hold” and a consensus target price of $4.60.

agilon health Stock Performance

NYSE AGL opened at $4.02 on Monday. The company’s 50 day simple moving average is $4.14 and its two-hundred day simple moving average is $3.11. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. agilon health, inc. has a 1 year low of $1.50 and a 1 year high of $7.73. The stock has a market capitalization of $1.66 billion, a PE ratio of -4.28 and a beta of 0.38.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.